Antenatal corticosteroids for early preterm birth: implementation strategy lessons from the WHO ACTION-I trial

The WHO ACTION-I trial, the largest placebo-controlled trial on antenatal corticosteroids (ACS) efficacy and safety to date, reaffirmed the benefits of ACS on mortality reduction among early preterm newborns i...

Source: Health Research Policy and Systems - December 28, 2022 Category: International Medicine & Public Health Authors: Ayesha De Costa, Olufemi T. Oladapo, Shuchita Gupta, Anayda Portela, Joshua P. Vogel, Joao Paulo Souza, Suman Rao, Nicole Minckas, Özge Tuncalp, Rajiv Bahl and Fernando Althabe Tags: Opinion Source Type: research